Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGM282 in Type 2 Diabetes Mellitus
NCT01943045Phase 2Completed
- Sponsor
- NGM Biopharmaceuticals
- Start
- Sep 2013
- Primary completion
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of aldafermin in type 2 diabetes mellitus (T2DM), sponsored by NGM Biopharmaceuticals. Started Sep 2013; status: completed.
02
Drugs
aldafermin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01943045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01943045.